549.1K XNAS Volume
XNAS 17 Apr, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Accuray Inc is on 01 May 2025 for the purpose of Accuray Inc Third Quarter Earnings Results for 2025
See details
Accuray Inc Key Metrics
Default
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTLow rank
4Positive17Negative
19.0% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Accuray Inc Stock Price Analysis
Day Price Range | 1.5 (LTP) 1.41.5 LowHigh |
Week Price Range | 1.5 (LTP) 1.41.5 LowHigh |
Month Price Range | 1.5 (LTP) 1.41.9 LowHigh |
52 Week Price Range | 1.5 (LTP) 1.43 LowHigh |
Accuray Inc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Accuray Inc's Revenue was higher than average estimate 2 times in past 3 years
Consensus Recommendation
4 ANALYST Recommendations
STRONG BUY
The consensus recommendation from 4 analysts for Accuray Inc is STRONG BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Accuray Inc Stock Analysis
Accuray Inc stock analysis with key metrics, changes, and trends.
Accuray Inc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $446.55 M | 0.24% | negative |
| |
Annual Net Profit | $15.54 M | 67.51% | negative |
| |
Price to Earning Ratio | -34.81 | - | negative |
| |
Stock Price | $1.48 | -30.84% | negative |
| |
Quarterly Revenue | $116.17 M | 8.33% | positive |
| |
Quarterly Net profit | $2.54 M | 126.37% | positive |
| |
Debt to Equity Ratio | 4.67 | - | negative |
| |
Return on Equity(ROE) | -31.49 % | -31.49% | negative |
| |
Mutual Fund Holding | 36.66 % | 0.81% | positive |
| |
Promoter Share Holding | 4.24 % | 0% | neutral |
| |
Interest Coverage Ratio | -0.02 | - | negative |
| |
Institutional Holding | 55.47 % | -0.02% | negative |
|
Loading data..
Accuray Inc - Company Profile
What does Accuray Inc do?
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Accuray Inc Management structure
All Gross Remunerations are in USD